Founded in 1982, Gilde is one of the oldest private equity firms in The Netherlands. Today, there are three independent investment partnerships, each with their own strategy and focus. To view the respective websites of these partnerships, you may click on the logos on the right hand side of this page.
Gilde Equity Management is an independent private equity company that invests in businesses that are rooted in the Benelux and have international aspirations. We do this in cases of business succession, privatization or management buyouts. We love companies that are fuelled by a love for what they do. Where people are proud of what they do or make. Where entrepreneurship is key. We invest capital, energy and our trust to help these companies and their management to flourish all over the world. The typical transaction value of our investments ranges between € 20 and € 200 million.
In February 2022, Gilde Buy Out Partners announced to the marketplace the adoption of a new name, reflective of the forward momentum of the organization. Now known as Rivean Capital, our team and core value proposition remains unchanged, as we continue to deliver creative growth solutions for aspiring business leaders.
We invite you to explore our updated website to see how we continue to be leaders in European mid-market private equity.
Gilde Healthcare is a specialized healthcare investor with €2 billion in funds raised for two strategies: Private Equity and Venture&Growth. The firm is headquartered in Utrecht (The Netherlands) with local offices in Frankfurt (Germany) and Cambridge (United States). The Private Equity fund of Gilde Healthcare participates in profitable healthcare companies based in North-west Europe. The Private Equity fund targets healthcare providers, suppliers of medical products and service providers with an EBITDA of €2 to €15 million. The Venture & Growth fund of Gilde Healthcare invests in digital health, medtech, instruments and therapeutics in Europe and North America.